Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2010

01.01.2010 | Clinical trial

Pain perception and detailed visual pain mapping in breast cancer survivors

verfasst von: Sebastian M. Jud, Peter A. Fasching, Christian Maihöfner, Katharina Heusinger, Christian R. Loehberg, Reinhard Hatko, Claudia Rauh, Hiba Bani, Michael P. Lux, Matthias W. Beckmann, Mayada R. Bani

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Chronic pain and neural irritation after breast surgery and radiation are still relevant sequelae of the treatment. Pain quantification and localization in patient groups are difficult to standardize. In order to quantify and localize pain in a group of breast cancer patients, a Java-based program was developed to visualize the frequency of pain in “pain maps.” A questionnaire with structured questions on the perception of pain included pictograms of a body to mark possible pain areas. A group of 343 breast cancer survivors completed the questionnaires. The image information was digitalized and processed using a Java applet. Gray-scale summation pictures with numbers from “0,” indicating black (100% pain), to “255,” indicating white (0% pain), were generated. The visualization of pain by creating pain maps revealed the location of pain in breast cancer survivors on pictograms of the body. Analyzing the total number of pixels, in which pain was stated, made it possible to compare pain areas in several subgroups, showing that patients after mastectomy versus breast-conserving therapy (3,011 vs. 2,224 pixels), and patients with lymphedema versus patients without lymphedema (3,010 vs. 2,239 pixels), have larger pain areas. This study presents a method of visualizing pain areas and assigning them to a pictogram of the body in a sample of breast cancer patients. The method is easy to use and could help generate pain maps in several types of disease.
Literatur
1.
Zurück zum Zitat Carpenter JS, Andrykowski MA, Sloan P et al (1998) Postmastectomy/postlumpectomy pain in breast cancer survivors. J Clin Epidemiol 51:1285–1292CrossRefPubMed Carpenter JS, Andrykowski MA, Sloan P et al (1998) Postmastectomy/postlumpectomy pain in breast cancer survivors. J Clin Epidemiol 51:1285–1292CrossRefPubMed
2.
Zurück zum Zitat Macdonald L, Bruce J, Scott NW et al (2005) Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome. Br J Cancer 92:225–230PubMed Macdonald L, Bruce J, Scott NW et al (2005) Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome. Br J Cancer 92:225–230PubMed
3.
Zurück zum Zitat Stevens PE, Dibble SL, Miaskowski C (1995) Prevalence, characteristics, and impact of postmastectomy pain syndrome: an investigation of women’s experiences. Pain 61:61–68CrossRefPubMed Stevens PE, Dibble SL, Miaskowski C (1995) Prevalence, characteristics, and impact of postmastectomy pain syndrome: an investigation of women’s experiences. Pain 61:61–68CrossRefPubMed
4.
Zurück zum Zitat Smith WC, Bourne D, Squair J et al (1999) A retrospective cohort study of post mastectomy pain syndrome. Pain 83:91–95CrossRefPubMed Smith WC, Bourne D, Squair J et al (1999) A retrospective cohort study of post mastectomy pain syndrome. Pain 83:91–95CrossRefPubMed
5.
Zurück zum Zitat Tasmuth T, von Smitten K, Hietanen P et al (1995) Pain and other symptoms after different treatment modalities of breast cancer. Ann Oncol 6:453–459PubMed Tasmuth T, von Smitten K, Hietanen P et al (1995) Pain and other symptoms after different treatment modalities of breast cancer. Ann Oncol 6:453–459PubMed
6.
Zurück zum Zitat Ferguson A (2007) Discovery of neuropathic pain following breast surgery. Br J Nurs 16:102PubMed Ferguson A (2007) Discovery of neuropathic pain following breast surgery. Br J Nurs 16:102PubMed
7.
Zurück zum Zitat Kehlet H, Jensen TS, Woolf CJ (2006) Persistent postsurgical pain: risk factors and prevention. Lancet 367:1618–1625CrossRefPubMed Kehlet H, Jensen TS, Woolf CJ (2006) Persistent postsurgical pain: risk factors and prevention. Lancet 367:1618–1625CrossRefPubMed
8.
Zurück zum Zitat Tatrow K, Montgomery GH (2006) Cognitive behavioral therapy techniques for distress and pain in breast cancer patients: a meta-analysis. J Behav Med 29:17–27CrossRefPubMed Tatrow K, Montgomery GH (2006) Cognitive behavioral therapy techniques for distress and pain in breast cancer patients: a meta-analysis. J Behav Med 29:17–27CrossRefPubMed
9.
Zurück zum Zitat Turp JC, Kowalski CJ, O’Leary N et al (1998) Pain maps from facial pain patients indicate a broad pain geography. J Dent Res 77:1465–1472CrossRefPubMed Turp JC, Kowalski CJ, O’Leary N et al (1998) Pain maps from facial pain patients indicate a broad pain geography. J Dent Res 77:1465–1472CrossRefPubMed
10.
Zurück zum Zitat Bani HA, Fasching PA, Lux MM et al (2007) Lymphedema in breast cancer survivors: assessment and information provision in a specialized breast unit. Patient Educ Couns 66:311–318CrossRefPubMed Bani HA, Fasching PA, Lux MM et al (2007) Lymphedema in breast cancer survivors: assessment and information provision in a specialized breast unit. Patient Educ Couns 66:311–318CrossRefPubMed
11.
Zurück zum Zitat Bani MR, Beckmann K, Engel J et al (2008) Correlates of the desire for improved cosmetic results after breast-conserving therapy and mastectomy in breast cancer patients. Breast 17(6):640–645CrossRefPubMed Bani MR, Beckmann K, Engel J et al (2008) Correlates of the desire for improved cosmetic results after breast-conserving therapy and mastectomy in breast cancer patients. Breast 17(6):640–645CrossRefPubMed
12.
Zurück zum Zitat Hamner JB, Fleming MD (2007) Lymphedema therapy reduces the volume of edema and pain in patients with breast cancer. Ann Surg Oncol 14:1904–1908CrossRefPubMed Hamner JB, Fleming MD (2007) Lymphedema therapy reduces the volume of edema and pain in patients with breast cancer. Ann Surg Oncol 14:1904–1908CrossRefPubMed
Metadaten
Titel
Pain perception and detailed visual pain mapping in breast cancer survivors
verfasst von
Sebastian M. Jud
Peter A. Fasching
Christian Maihöfner
Katharina Heusinger
Christian R. Loehberg
Reinhard Hatko
Claudia Rauh
Hiba Bani
Michael P. Lux
Matthias W. Beckmann
Mayada R. Bani
Publikationsdatum
01.01.2010
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2010
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-009-0485-z

Weitere Artikel der Ausgabe 1/2010

Breast Cancer Research and Treatment 1/2010 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.